Form D/A - Notice of Exempt Offering of Securities: [Amend]
SEC Accession No. 0000919574-20-003491
Filing Date
2020-05-15
Accepted
2020-05-15 08:05:20
Documents
1
Effectiveness Date
2020-05-15
Items
Item 06b:
Item 3C: Investment Company Act Section 3(c)
Item 3C.7: Section 3(c)(7)

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D/A  
1 primary_doc.xml D/A 6388
  Complete submission text file 0000919574-20-003491.txt   7574
Mailing Address 3000 SAND HILL ROAD BUILDING 4, SUITE 250 MENLO PARK CA 94025
Business Address 3000 SAND HILL ROAD BUILDING 4, SUITE 250 MENLO PARK CA 94025 650-681-8482
Sofinnova BioEquities, LP (Filer) CIK: 0001706472 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D/A | Act: 33 | File No.: 021-286773 | Film No.: 20880675